Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: A comparison before and after 2006

Amyloid

Volumn 18, Issue SUPPL. 1, 2011, Pages 137-138

  Gertz, M A ^a   Lacy, M Q ^a   Dispenzieri, A ^a   Kumar, S ^a   Hayman, S R ^a   Buadi, F ^a   Dingli, D ^a   Leung, N ^a   Hogan, W J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA 2 MICROGLOBULIN; TROPONIN T;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; FEMALE; HUMAN; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREND STUDY;

EID: 79959968213     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.574354     Document Type: Article

References (6)

1. Gertz M, Lacy M, Dispenzieri A, Amena S, Kumar S, Buadi F, Leung N, Litzow M. Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis. Leuk Lymphoma 2008;49:36-41. (Pubitemid 351146880)
2. Comenzo RL. How I treat amyloidosis. Blood 2009;114:3147-3157.
3. Gertz MA, Zeldenrust SR. Treatment of immunoglobulin light chain amyloidosis. Curr Hematol Malign Rep 2009;4:91-98.
4. Yoshizawa S, Akahane D, Fujimoto H, Gotoh M, Kiguchi T, Tauchi T, Ohyashiki K. Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvement. Rinsho Ketsueki 2009;50:1647-1651.
5. Vesole DH, Perez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study. Mayo Clin Proc 2006;81:880-888. (Pubitemid 43993479)
6. Bellavia D, Pellikka PA, Al-Zahrani GB, Abraham TP, Dispenzieri A, Miyazaki C, Lacy M, Scott CG, Oh JK, Miller FA. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 2010;23:643-652.